the treatment of obesity
Semaglutide vs. Tirzepatide: Choosing the Best GLP‑1 Weight‑Loss Treatment
Semaglutide and tirzepatide are the leading prescription drugs for adult obesity, together representing a frontline strategy for weight loss. These GLP-1 receptor agonists have become essential tools in the medical weight-loss arsenal. About 40% of U.S. adults are classified as obese, making prescription weight-loss drugs a public-health priority (nature.